What is Incyte's work in process?

Incyte (INCY) reported work in process of $351.58M in Q1 2026.

How has Incyte's work in process changed year-over-year?

Incyte's work in process decreased by 0.1% year-over-year, from $351.91M to $351.58M.

What is the long-term trend for Incyte's work in process?

Over 4 years (2021 to 2025), Incyte's work in process has grown at a 71.3% compound annual growth rate (CAGR), from $39.9M to $343.68M.

Current Assets

Work in process

Incyte Work in process increased by 2.3% to $351.58M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $351.91M to $351.58M. Over 4 years (FY 2021 to FY 2025), Work in process shows an upward trend with a 71.3% CAGR.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

First reportedQ4 2021

Last reportedQ1 2026Apr 28, 2026

Parent metricInventories

Metric ID: inv_work_in_progress

Historical Data

16 periods

	Q4 '21	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$39.9M	$35.47M	$54.46M	$93.83M	$122.97M	$140.37M	$209.79M	$255.04M	$284.71M	$285.5M	$331.18M	$351.91M	$361.74M	$354.36M	$343.68M	$351.58M
QoQ Change	—	-11.1%	+53.5%	+72.3%	+31.1%	+14.1%	+49.5%	+21.6%	+11.6%	+0.3%	+16.0%	+6.3%	+2.8%	-2.0%	-3.0%	+2.3%
YoY Change	—	—	+36.5%	—	—	+295.8%	+285.3%	+171.8%	+131.5%	+103.4%	+57.9%	+38.0%	+27.1%	+24.1%	+3.8%	-0.1%
% of Inventories	137.4%	64.2%	69.0%	80.4%	86.6%	98.8%	101.4%	96.5%	111.5%	95.8%	95.1%	96.3%	98.3%	96.7%	100.4%	106.1%
Share Change	—	-73.2pp	+4.8pp	+11.4pp	+6.2pp	+12.2pp	+2.6pp	-4.9pp	+15.0pp	-15.7pp	-0.7pp	+1.3pp	+1.9pp	-1.6pp	+3.7pp	+5.7pp

Range$35.47M – $361.74M

CAGR+78.7%

Avg YoY Growth+97.9%

Median YoY Growth+47.9%

Work in process at Other Companies

PfizerPFE View metric

Gilead SciencesGILD View metric

AbbVieABBV View metric

AmgenAMGN View metric

BiogenBIIB View metric

Regeneron PharmaceuticalsREGN View metric

Frequently Asked Questions

What is Incyte's work in process?: Incyte (INCY) reported work in process of $351.58M in Q1 2026.
How has Incyte's work in process changed year-over-year?: Incyte's work in process decreased by 0.1% year-over-year, from $351.91M to $351.58M.
What is the long-term trend for Incyte's work in process?: Over 4 years (2021 to 2025), Incyte's work in process has grown at a 71.3% compound annual growth rate (CAGR), from $39.9M to $343.68M.